Form 8-K Jounce Therapeutics, For: Aug 07
Jounce Therapeutics, Inc. (JNCE)
Last jounce therapeutics, inc. earnings: 2/27 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.jouncetx.com
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
JNCE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNCE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNCE alerts
High impacting Jounce Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
JNCE
News
- Jounce Therapeutics, Inc. (<a href="https://www.marketbeat.com/stocks/NASDAQ/JNCE/price-target/">NASDAQ: JNCE</a>) had its price target lowered by analysts at Piper Sandler from $17.00 to $9.00.MarketBeat
- Jounce Therapeutics To Present At Upcoming Investor Conferences [TheStreet.com]TheStreet.com
- Jounce Therapeutics to Present at Upcoming Investor ConferencesGlobeNewswire
- Data-Driven Insights for Effective Clinical Trial Oversight, Upcoming Webinar Hosted by XtalksPR Web
- Jounce Therapeutics slides after Baird pulls bullish view on JTX-8064 concerns [Seeking Alpha]Seeking Alpha
JNCE
Earnings
- 5/5/22 - Miss
JNCE
Sec Filings
- 6/28/22 - Form 4
- 6/28/22 - Form 4
- 6/28/22 - Form 4
- JNCE's page on the SEC website